Evidence map›Paper›PMID 36551180›Full record

ArticleBiomolecules2022

Hilman Nurmahdi, Mao Hasegawa, Elzava Yuslimatin Mujizah, Takeshi Sasamura, Mikiko Inaki, Shinya Yamamoto, Tomoko Yamakawa, Kenji Matsuno

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Examining the contribution of Notch signaling to lung disease development.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  6. Review
  7. Article
  8. Progress to Clarify HowBiomolecules · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hilman NurmahdiDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Mao HasegawaDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Elzava Yuslimatin MujizahDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Takeshi SasamuraDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Mikiko InakiDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Shinya YamamotoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0003-2172-8036
Tomoko YamakawaDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.
Kenji MatsunoDepartment of Biological Science, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.ORCID 0000-0001-6140-8833
The University of Osaka · JPBaylor College of Medicine · US

Funding

Japan Society for the Promotion of Science JP18K14697Toyota Riken Scholar 2020
6 · The paper itself

Abstract

Notch signaling plays various roles in cell-fate specification through direct cell-cell interactions. Notch receptors are evolutionarily conserved transmembrane proteins with multiple epidermal growth factor (EGF)-like repeats.

Indexed as

Drosophila ProteinsEpidermal Growth FactorAnimalsDrosophilaMutation, MissenseReceptors, NotchDrosophila ProteinsEpidermal Growth FactorReceptors, Notchasymmetric cell divisionDrosophilaendoplasmic reticulumhindgutintracellular traffickinglateral inhibitionneurogenic phenotypeNotchNotch signaling pathwayprotein folding

Identifiers

PMID36551180
PMCPMC9775759
OpenAlexW4310214762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.